Tosk Inc. is a biopharmaceutical company based in Mountain View, CA, dedicated to enhancing cancer treatment outcomes by developing innovative drugs that target the adverse effects of existing therapies and block cancer gene activity. Their proprietary methods focus on creating cost-effective, small molecule drugs that aim to improve treatment regimens globally.
With a mission to improve patient quality of life, Tosk is at the forefront of discovering solutions for indications previously deemed untreatable, starting with the mutant KRAS gene that plays a role in a significant portion of cancer cases. Through their cutting-edge technology and commitment to innovation, Tosk is revolutionizing cancer therapy and paving the way for more effective and personalized treatment options.
Generated from the website